SV

Street Verdict

Analyst Scorecard

EVOQ.BO · BSE

Evoq Remedies Limited

₹1.79

+4.68% (+₹0.08)

Prev. close

₹1.71

Volume

24,000

As of

20 Nov 2026

Price history

₹1.79-₹0.05 (-2.72%) · 3M
10 Aug 2026 → 20 Nov 2026
1.41.51.61.71.81.910 Aug03 Sept29 Sept28 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

No analyst stances in this range

0 analyst stances · last 90 days · one per analyst

Try a wider range — no analyst has covered this yet.

Explore by date range →

Analyst opinions

No analyst calls on Evoq Remedies Limited yet.

Fundamentals

About Evoq Remedies Limited

Evoq Remedies Limited engages in the pharmaceutical business in India. The company trades in and acts as a commission agent for pharmaceutical products. It also manufactures, distributes, and exports commercial grade, refined, pale pressed grade, and first pressed degummed castor oils; castor oil and de oil cakes; and high protein castor meals. Evoq Remedies Limited was incorporated in 2010 and is based in Ahmedabad, India.

Details

Sector

Healthcare

Industry

Medical Distribution

CEO

Mr. Bhumishth Narendrabhai Patel

Headquarters

Ahmedabad

Key stats

Market cap

₹3.83 Cr

Dividend yield

0.00%

EPS (TTM)

₹-0.10

Beta (1Y · daily vs NIFTY 50)

0.99

Beta (5Y · monthly vs NIFTY 50)

2.23

Shares float

1.52 Cr

Financial Performance

01 · Financials

-20 Cr0 Cr20 Cr40 Cr₹-10%0%10%20%FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

00.511.5₹FY22FY23FY24FY25

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-200%0%200%400%FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

Left off as not meaningful (growth from a very small base, beyond ±400%): Fixed assets FY25 (+1494%).

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr20 Cr40 Cr60 Cr₹0×0.2×0.4×0.6×FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr20 Cr40 Cr60 Cr₹FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

-20 Cr-10 Cr0 Cr10 Cr₹FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY22FY23FY24FY25FY26
₹16.78 Cr₹20.39 Cr₹4.05 Cr₹11.76 Cr₹25.51 Cr
EBITDA
—₹-3.73 Cr₹-1.58 Cr₹17.71 L₹-19.99 L
₹1.09 Cr₹1.62 Cr₹45.24 L₹8.82 L₹-23.99 L
Diluted EPS
₹0.7₹1.19₹0.33₹0.06—

Depreciation & amortisation, EBITDA, Pretax income, Tax provision, Interest expense, Diluted EPS have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY22FY23FY24FY25FY26
—₹34.90 Cr₹36.86 Cr₹50.01 Cr₹51.94 Cr
—₹9.58 Cr₹4.24 Cr₹0₹7.30 L
Stockholders' equity
—₹24.79 Cr₹25.24 Cr₹44.54 Cr₹44.30 Cr

Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY22FY23FY24FY25FY26
—₹-4.35 Cr₹5.32 Cr₹-14.62 Cr₹-28.19 L
Investing cash flow
—₹-1.31 L₹-1.20 L₹-25.81 L₹0
—₹1.42 Cr₹-5.34 Cr₹14.97 Cr₹7.30 L
Capital expenditure
—₹-1.31 L₹-1.20 L₹-25.81 L—
End cash position
—₹15.36 L₹12.34 L₹21.41 L₹52,000

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
Evoq Remedies Limited₹4.08 Cr₹1.63—0.09-0.5%0.00+117.0%-66.8%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

No stock news captured yet.